Seizures in the critically I11: The role of imipenem

Epilepsia

Volumn 42, Issue 12, 2001, Pages 1590-1593

  Koppel, Barbara S ^a   Hauser, Allen ^b   Politis, Chrissoula ^a   Van Duin, David ^c   Daras, Michael ^a  

^a METROPOLITAN HOSPITAL CENTER   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Columbia University ^*  (United States)

Author keywords

Antibiotic adverse events; Critical illness and seizure risk; Epilepsy; Imipenem

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; GLUTAMATE RECEPTOR; IMIPENEM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENYTOIN; ANTIINFECTIVE AGENT;

ADULT; ANOXIA; ANTIBIOTIC THERAPY; ARTICLE; BODY MASS; CONTROLLED STUDY; CRITICAL ILLNESS; DEMOGRAPHY; DOSE KIDNEY FUNCTION RELATION; DRUG SAFETY; DRUG UTILIZATION; DRUG WITHDRAWAL; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; METABOLIC DISORDER; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEIZURE; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG ADMINISTRATION; EPILEPSY; LIFE TABLE; MEDICAL RECORD; TREATMENT OUTCOME;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EPILEPSY; HOSPITAL RECORDS; HOSPITALIZATION; HUMANS; IMIPENEM; INCIDENCE; LIFE TABLES; RISK FACTORS; SEIZURES; TREATMENT OUTCOME;

EID: 0035543834     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2001.34701.x     Document Type: Article

References (16)

1. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: Experience with imipenem/cilastin
2. Imipenem
3. Neurotoxicity of β-lactam antibiotics: Predisposing factors and pathogenesis
4. Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice
5. Structural features resulting in convulsive activity of carbapenem compounds: Effect of C-2 side chain
6. Seizure activity with imipenem therapy: Incidence and risk factors
7. Efficacy and safety of imipenem/cilastin: A review of worldwide clinical experience
8. Adverse effects of monobactams and carbapenems
9. Seizures in patients simultaneously receiving theophylline and imipenem or ciprofloxacin or metronidazole
10. Seizure activity associated with imipenem use: Clinical case reports and review of the literature
11. Prospective surveillance of imipenem/cilastin use and associated seizures using a hospital information system
12. Maximum utilization of the life table method in analyzing survival
13. Incomplete mortality data: Follow-up studies
14. New-onset seizures in critically ill patients
15. Safety profile of meropenem: A review of nearly 5,000 patients treated with meropenem
16. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidine with tobramycin: A randomized study